APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Preventive Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Preventive Vaccines Market Outlook and Growth Opportunities 2026

Report ID 174028430422 December 2025198 pages

Choose your research edition.

Industry ResearchPreventive Vaccines Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Preventive Vaccines Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Preventive Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Preventive Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Preventive Vaccines Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Preventive Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Preventive Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Preventive Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Preventive Vaccines market include Abbott, Sanofi, GlaxoSmithKline, AstraZeneca, Serum Institute of India and CSL Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Preventive Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Preventive Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Preventive Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Preventive Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Preventive Vaccines Segment by Company

Abbott

Sanofi

GlaxoSmithKline

AstraZeneca

Serum Institute of India

CSL Ltd

Preventive Vaccines Segment by Type

Intradermal Shot

Intramuscular Injection

Nasal Spray

Preventive Vaccines Segment by Application

Hospital

Clinic

Other

Preventive Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Preventive Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Preventive Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Preventive Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Preventive Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Preventive Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Preventive Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Preventive Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Preventive Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Preventive Vaccines industry.

Chapter 3: Detailed analysis of Preventive Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Preventive Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Preventive Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Preventive Vaccines Industry Trends Table 2. Preventive Vaccines Industry Drivers Table 3. Preventive Vaccines Industry Opportunities and Challenges Table 4. Preventive Vaccines Industry Restraints Table 5. Global Preventive Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Preventive Vaccines Revenue Share by Company (2021-2026) Table 7. Global Preventive Vaccines Sales Volume by Company (doses) & (2021-2026) Table 8. Global Preventive Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Preventive Vaccines Average Price (US$/dose) of Company (2021-2026) Table 10. Global Preventive Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Preventive Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Preventive Vaccines Company, Product Type & Application Table 13. Global Preventive Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Preventive Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Intradermal Shot Table 18. Significant Companies of Intramuscular Injection Table 19. Significant Companies of Nasal Spray Table 20. Global Preventive Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (doses) Table 21. Global Preventive Vaccines Sales Volume by Type (2021-2026) & (doses) Table 22. Global Preventive Vaccines Sales Volume by Type (2027-2032) & (doses) Table 23. Global Preventive Vaccines Sales Volume Share by Type (2021-2026) Table 24. Global Preventive Vaccines Sales Volume Share by Type (2027-2032) Table 25. Global Preventive Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Preventive Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Preventive Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Preventive Vaccines Sales Value Share by Type (2021-2026) Table 29. Global Preventive Vaccines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Preventive Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (doses) Table 34. Global Preventive Vaccines Sales Volume by Application (2021-2026) & (doses) Table 35. Global Preventive Vaccines Sales Volume by Application (2027-2032) & (doses) Table 36. Global Preventive Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Preventive Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Preventive Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Preventive Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Preventive Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Preventive Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Preventive Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032 (doses) Table 44. Global Preventive Vaccines Sales by Region (2021-2026) & (doses) Table 45. Global Preventive Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Preventive Vaccines Sales by Region (2027-2032) & (doses) Table 47. Global Preventive Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Preventive Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Preventive Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Preventive Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Preventive Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Preventive Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Preventive Vaccines Market Average Price (US$/dose) by Region (2021-2026) Table 54. Global Preventive Vaccines Market Average Price (US$/dose) by Region (2027-2032) Table 55. Global Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032 (doses) Table 56. Global Preventive Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Preventive Vaccines Sales by Country (2021-2026) & (doses) Table 58. Global Preventive Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Preventive Vaccines Sales by Country (2027-2032) & (doses) Table 60. Global Preventive Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Preventive Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Preventive Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Preventive Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Preventive Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 68. Abbott Preventive Vaccines Product Portfolio Table 69. Abbott Recent Development Table 70. Sanofi Company Information Table 71. Sanofi Business Overview Table 72. Sanofi Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 73. Sanofi Preventive Vaccines Product Portfolio Table 74. Sanofi Recent Development Table 75. GlaxoSmithKline Company Information Table 76. GlaxoSmithKline Business Overview Table 77. GlaxoSmithKline Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 78. GlaxoSmithKline Preventive Vaccines Product Portfolio Table 79. GlaxoSmithKline Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 83. AstraZeneca Preventive Vaccines Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Serum Institute of India Company Information Table 86. Serum Institute of India Business Overview Table 87. Serum Institute of India Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 88. Serum Institute of India Preventive Vaccines Product Portfolio Table 89. Serum Institute of India Recent Development Table 90. CSL Ltd Company Information Table 91. CSL Ltd Business Overview Table 92. CSL Ltd Preventive Vaccines Sales (doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 93. CSL Ltd Preventive Vaccines Product Portfolio Table 94. CSL Ltd Recent Development Table 95. Key Raw Materials Table 96. Raw Materials Key Suppliers Table 97. Preventive Vaccines Distributors List Table 98. Preventive Vaccines Customers List Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Preventive Vaccines Product Image Figure 2. Global Preventive Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Preventive Vaccines Sales (2021-2032) & (doses) Figure 5. Global Preventive Vaccines Sales Average Price (US$/dose) & (2021-2032) Figure 6. Global Preventive Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Intradermal Shot Image Figure 10. Intramuscular Injection Image Figure 11. Nasal Spray Image Figure 12. Global Preventive Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (doses) Figure 13. Global Preventive Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Preventive Vaccines Sales Volume Share by Type (2021-2032) Figure 15. Global Preventive Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Preventive Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Preventive Vaccines Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Preventive Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (doses) Figure 22. Global Preventive Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Preventive Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Preventive Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Preventive Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Preventive Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032 (doses) Figure 28. Global Preventive Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Preventive Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Preventive Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Preventive Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Preventive Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Preventive Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Preventive Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Preventive Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Preventive Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Preventive Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Preventive Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Preventive Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Preventive Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Preventive Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Intradermal Shot
  • Intramuscular Injection
  • Nasal Spray
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Abbott
  • Sanofi
  • GlaxoSmithKline
  • AstraZeneca
  • Serum Institute of India
  • CSL Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Preventive Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Preventive Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Preventive Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Preventive Vaccines Market Dynamics
  1. 2.1 Preventive Vaccines Industry Trends
  2. 2.2 Preventive Vaccines Industry Drivers
  3. 2.3 Preventive Vaccines Industry Opportunities and Challenges
  4. 2.4 Preventive Vaccines Industry Restraints
3 Preventive Vaccines Market by Company
  1. 3.1 Global Preventive Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Preventive Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Preventive Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Preventive Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Preventive Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Preventive Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Preventive Vaccines Company Product Type and Application
  8. 3.8 Global Preventive Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Preventive Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Preventive Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Preventive Vaccines Market by Type
  1. 4.1 Preventive Vaccines Type Introduction
  2. 4.1.1 Intradermal Shot
  3. 4.1.2 Intramuscular Injection
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Preventive Vaccines Sales Volume by Type
  6. 4.2.1 Global Preventive Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Preventive Vaccines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Preventive Vaccines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Preventive Vaccines Sales Value by Type
  10. 4.3.1 Global Preventive Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Preventive Vaccines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Preventive Vaccines Sales Value Share by Type (2021-2032)
5 Preventive Vaccines Market by Application
  1. 5.1 Preventive Vaccines Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Preventive Vaccines Sales Volume by Application
  6. 5.2.1 Global Preventive Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Preventive Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Preventive Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Preventive Vaccines Sales Value by Application
  10. 5.3.1 Global Preventive Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Preventive Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global Preventive Vaccines Sales Value Share by Application (2021-2032)
6 Preventive Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Preventive Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Preventive Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Preventive Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Preventive Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Preventive Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Preventive Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Preventive Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Preventive Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Preventive Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Preventive Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Preventive Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Preventive Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Preventive Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Preventive Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Preventive Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Preventive Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Preventive Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Preventive Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Preventive Vaccines Sales Value Share by Country, 2025 VS 2032
7 Preventive Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Preventive Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Preventive Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Preventive Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Preventive Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Preventive Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Preventive Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Preventive Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Preventive Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Preventive Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Preventive Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Preventive Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Preventive Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Preventive Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Preventive Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Preventive Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Preventive Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Preventive Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Preventive Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Preventive Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Preventive Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Preventive Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Preventive Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Preventive Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Preventive Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Preventive Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Preventive Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Preventive Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Preventive Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Preventive Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Preventive Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Preventive Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Preventive Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Preventive Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Preventive Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Preventive Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Preventive Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Preventive Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Preventive Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Preventive Vaccines Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Preventive Vaccines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Preventive Vaccines Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Preventive Vaccines Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Serum Institute of India
  26. 8.5.1 Serum Institute of India Company Information
  27. 8.5.2 Serum Institute of India Business Overview
  28. 8.5.3 Serum Institute of India Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Serum Institute of India Preventive Vaccines Product Portfolio
  30. 8.5.5 Serum Institute of India Recent Developments
  31. 8.6 CSL Ltd
  32. 8.6.1 CSL Ltd Company Information
  33. 8.6.2 CSL Ltd Business Overview
  34. 8.6.3 CSL Ltd Preventive Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CSL Ltd Preventive Vaccines Product Portfolio
  36. 8.6.5 CSL Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Preventive Vaccines Value Chain Analysis
  2. 9.1.1 Preventive Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Preventive Vaccines Sales Mode & Process
  6. 9.2 Preventive Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Preventive Vaccines Distributors
  9. 9.2.3 Preventive Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst